Search Results for "Temovate Scalp"
Original Source: Temovate [PharmaDerm®, A division of Nycomed US Inc.]
TEMOVATE (clobetasol propionate scalp application)Scalp Application, 0.05%
Matching Channels
Xeroderma, literally meaning "dry skin", is a condition involving the integumentary system, which in most cases can safely be treated with emollients and/or moisturizers. Xeroderma occurs...
Matching News
FDA approves Sorilux for scalp psoriasis
The Food and Drug Administration has approved Sorilux Foam 0.005 percent for the topical treatment of plaque psoriasis of the scalp.
Rare condition causes scalp thickening
An unusual condition in which excessive growth of the scalp results in ridges and furrows resembling the brain’s surface has been demonstrated in a case study.
FDA Approves Scalp-Cooling For Chemo Hair Loss Final Trial
Dignitana, a world leader in medical scalp-cooling technology, has announced that it has received U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) applic...
Zincplex Releases Extra Strength Version For Scalp Flaking and Itching
The top rated herbal scalp shampoo releases an extra strength version. Chattanooga, TN (PRWEB) July 25, 2012 For years Zincplex has been producing an herbal alternative for people that want help with...
FDA approves Stiefel’s Sorilux Foam sNDA to treat for scalp psoriasis
Stiefel, a GSK company, today announced that the US Food and Drug Administration has approved a supplemental New Drug Application (sNDA) for Sorilux (calcipotriene) Foam, 0.005%. The sNDA expands the...
Ingenol mebutate provides sustained clearance of lesions
Nearly half of patients with actinic keratoses who respond well to treatment with ingenol mebutate gel remain free of lesions at one year, according to trial follow-up data. Researchers have repor...
ScalpMed Hair Growth Product Receives New U.S. Patent
NHSI receives new patent for its ScalpMed system designed to regrow an individual's natural hair proven effective for both men and women. Culver City, CA (PRWEB) June 17, 2013 NHSI, Inc. announce...
Taclonex Approved for Body Plaque Psoriasis
The vitamin D/corticosteroid suspension is now indicated for scalp and body plaque psoriasis. FDA Approvals
Matching PubMed Articles
Chemotherapy-induced alopecia is a commonly feared chemotherapy side effect and can be prevented using scalp cooling. Scalp metastasis is a rare site of recurrence. There is a question about whether o...
Specular light reflectance of flakes in seborrhoeic dermatitis of the scalp: a pilot study.
Seborrhoeic dermatitis and dandruff are common scalp conditions. In this study, we set out to explore a new method for rating both the severity of the scalp condition and the efficacy of scalp-care co...
Scalp psoriasis: an overview of the disease and available therapies.
The scalp is one of the regions of the body most commonly affected by psoriatic lesions. While the head represents only 10 percent of the body's surface area, the consequences of scalp psoriasis are d...
Clinical and Dermoscopic Features of 88 Scalp Nevi in 39 Children.
Background: Paediatric scalp nevi may represent a source of anxiety for practitioners and parents, as the clinical and dermoscopic features of typical nevi have yet to be defined. Prompted by conce...
Treating Cutis Verticis Gyrata Using Skin Expansion Method.
The objective of this study was to evaluate the feasibility and clinical effect of repairing scalp defect after the excision of cutis verticis gyrata using expanded scalp skin flaps. For this purpose,...